Neural mechanisms of perceptual learning

The traditional view of cortical visual processing is that primary visual cortex (V1) analyzes simple visual attributes, and that object recognition involves a progressive “complexification” of receptive field (RF) properties along the visual pathway extending into the temporal lobe. Based on our studies with a combination of electrophysiological, imaging, psychophysical and computational approaches, we find to the contrary that V1 is capable of encoding much more complex stimulus features than originally believed, and that it can integrate information over large parts of the visual field. Moreover, V1 is continually involved in encoding information about learned stimulus configurations under top-down influences specific to the trained perceptual task.     

Catecholamines in adult iron deficiency patients.

Patients with iron deficiency whether uncomplicated or associated with other types of anemias, had plasma catecholamine levels which were significantly increased above normal controls. Patients with a variety of other anemias had no significant increase in catecholamine levels. Plasma catecholamine levels in uncomplicated iron deficient patients approached normal values as early as 3 h following oral FeSO4.     

Neural mechanisms of perceptual learning

The traditional view of cortical visual processing is that primary visual cortex (V1) analyzes simple visual attributes, and that object recognition involves a progressive “complexification” of receptive field (RF) properties along the visual pathway extending into the temporal lobe. Based on our studies with a combination of electrophysiological, imaging, psychophysical and computational approaches, we find to the contrary that V1 is capable of encoding much more complex stimulus features than originally believed, and that it can integrate information over large parts of the visual field. Moreover, V1 is continually involved in encoding information about learned stimulus configurations under top-down influences specific to the trained perceptual task.     

Late middle Eocene epoch of Libya yields earliest known radiation of African anthropoids

Reconstructing the early evolutionary history of anthropoid primates is hindered by a lack of consensus on both the timing and biogeography of anthropoid origins. Some prefer an ancient (Cretaceous) origin for anthropoids in Africa or some other Gondwanan landmass, whereas others advocate a more recent (early Cenozoic) origin for anthropoids in Asia, with subsequent dispersal of one or more early anthropoid taxa to Africa. The oldest undoubted African anthropoid primates described so far are three species of the parapithecid Biretia from the late middle Eocene Bir El Ater locality of Algeria and the late Eocene BQ-2 site in the Fayum region of northern Egypt. Here we report the discovery of the oldest known diverse assemblage of African anthropoids from the late middle Eocene Dur At-Talah escarpment in central Libya. The primate assemblage from Dur At-Talah includes diminutive species pertaining to three higher-level anthropoid clades (Afrotarsiidae, Parapithecidae and Oligopithecidae) as well as a small species of the early strepsirhine primate Karanisia. The high taxonomic diversity of anthropoids at Dur At-Talah indicates either a much longer interval of anthropoid evolution in Africa than is currently documented in the fossil record or the nearly synchronous colonization of Africa by multiple anthropoid clades at some time during the middle Eocene epoch.     

Suppressor effects and cyclic AMP accumulation by the CD29 molecule of CD4+ lymphocytes

Integrins are a superfamily of related molecules whose function, where known, is to mediate adhesion. The so-called very-late-activation antigen (VLA) family includes at least five distinct heterodimers, each composed of a unique alpha-subunit non-covalently associated with a common beta-subunit. Several members of the family have been shown to bind extracellular matrix proteins, but the function of VLA-4 is so far unknown. VLA-4 is the only member of the family detected on thymocytes and resting T cells. We show here that an antibody which recognizes the beta-subunit of VLA-4 (CD29) on T cells can inhibit CD4+ cell proliferation triggered by CD2 or CD3, and that binding of this antibody to activated T cells leads to an increase in cyclic AMP levels which is comparable to that elicited by forskolin. These negative signalling effects are unique to this antibody: other CD29 antibodies do not affect the growth of activated CD4 cells but enhance the proliferation of whole T cell populations and abrogate the suppressive effects of mitomycin-treated CD8 cells on CD4-cell growth. Taken together, our results indicate that VLA-4 functions in cell-cell interactions and that it is the target for the suppressive effects of CD8 cells on CD4 cells.